原創 九叔 39健康網

參考資料：

[1] Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study，Published:February 14, 2022,DOI:https://doi.org/10.1016/j.lana.2022.100198

[2] Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study,Published:December 21, 2021,DOI:https://doi.org/10.1016/j.lana.2021.100154

[3] Ministerio de Salud丨Chile realiza primer estudio a nivel mundial sobre uso de dosis de refuerzo en vacunas inactivadas: Aumenta efectividad en prevención y hospitalización por COVID-19，https://www.minsal.cl/chile-realiza-primer-estudio-a-nivel-mundial-sobre-uso-de-dosis-de-refuerzo-en-vacunas-inactivadas-aumenta-efectividad-en-prevencion-y-hospitalizacion-por-covid-19/

[4] Pan HX, Wu QH, Zeng G, et al. Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial. medrxiv. 2021.07.23.21261026v1.

[5] Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile，September 2, 2021，N Engl J Med 2021; 385:875-884，DOI: 10.1056/NEJMoa2107715

[6] 新華社丨智利研究稱加強針可大幅提高新冠疫苗有效率，http://www.news.cn/2021-10/08/c_1127938080.htm

[7] 王長征. 新型冠狀病毒肺炎疫苗研究開發現狀和面臨的挑戰[J]. 國際呼吸雜志,2021,41(17):1281-1285. DOI:10.3760/cma.j.cn131368-20210323-00227.

[8] 陳維剛. 新冠疫苗是怎樣提供保護作用的[J]. 保健與生活,2021(21):38-39.

閱讀原文